Home / News / Why Appen continues to sink

Why Appen continues to sink

News

The Appen Ltd (ASX: APX) share price is well into the red today after Macquarie Group Ltd (ASX: MQG) downgraded its Appen price target from $11.80 to $9.50.

Subsequently, the Appen share price has plummeted 14.43% to $9.96.

It’s been quite the fall from grace for the artificial intelligence labour-hire company, with its share price now 75% below its highs in 2020.

  • APX share price

    Source: Rask Media APX 2-year share price

    Macquarie sinks Appen

    Macquarie believes Appen could potentially downgrade its guidance in the coming weeks.

    This comes after the business reiterated FY22 guidance of $81-$88 million in EBITDA in August:

    “…we’re maintaining our guidance range, but expect to be at the lower end of the range due to the ad-related project impacts”

    Historically, Appen has provided an earnings update for the remainder of the year before Christmas.

    In 2018 and 2019, it upgraded its guidance in mid-November. And in 2020 it downgraded its guidance in December.

    Appen’s revenue is somewhat unpredictable, given a majority of it is project-related. Therefore its results can fluctuate half-on-half and year-on-year.

    However, more recently the company has faced delays in customer spending and reallocation of resources towards new projects Appen is not involved with (yet).

    Macquarie also noted after discussions with industry participants, big-tech companies are looking to directly crowdsource annotation services.

    This negatively impacts Appen, whose revenue is largely from the likes of Microsoft, Google and Facebook.

    What next for the Appen share price?

    It’s difficult to get excited by Appen at the moment.

    The company is in a downgrade cycle and the market isn’t kind to businesses that continually revise guidance.

    Last year’s downgrade came somewhat out of the blue and management noted it was a temporary setback at the time.

    In fact, revenue was anticipated to return to industry growth rates of 30%.

    Unfortunately, for Appen shareholders, it looks like further pain is still on the horizon.

    On a positive note, Appen’s bigger competitor, Lionbridge was recently acquired for a higher earnings multiple than Appen is currently trading on.

    However, that is no guarantee Appen will be purchased for a similar price, or even act as a base for its share price.

    For now, I’m avoiding Appen shares.

    Information warning: The information in this article was published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169

    Lachlan Buur-Jensen

    Lachlan is a Bachelor of Commerce graduate with majors in Accounting and Finance from Monash University. He invests in companies with intense customer love, strongly aligned management teams and structural tailwinds. Lachlan is a big proponent of the eighth wonder of the world - compound returns, and its power in helping individuals reach financial freedom. Outside of investing, Lachlan enjoys supporting his AFL team - Essendon. Albeit, this can be frustrating at the best of times.




    Print Article

    Related
    Pilot project validates need for national dental scheme for seniors

    A groundbreaking practical exercise that tackled the oral health of 70 socio-economically disadvantaged Sydneysiders delivered concrete benefits in managing tooth decay and gum disease.

    Nicholas Way | 30th Apr 2025 | More
    Elderly fears about falling increase the likelihood of it occurring

    Falls account for about 400 people – many of them seniors – being admitted to hospital daily. It’s a distressing number because research shows about 30 per cent are preventable.

    Nicholas Way | 23rd Apr 2025 | More
    Aged care needs to ‘urgently adopt’ Artificial Intelligence

    A scientific futurist draws a positive picture of how technology can revolutionise care, efficiency and safety for the benefit of both residents and nursing staff.

    Nicholas Way | 23rd Apr 2025 | More
    Popular